| Active Ingredient | FLUNARIZINE |
| Therapeutic Class | ANTIMIGRAINE AGENTS MISCELLANEOUS |
| Indications | Prophylaxis of migraine headache, peripheral vascular disease; vertigo. |
| Caution | To be taken at bedtime to reduce CNS symptoms. Weight gain may occur in pediatrics. Sedation and drowsiness. |
| Dose Range |
Migraine Prophylaxis: 10mg at bedtime. Peripheral Vascular Disease: 10-20mg daily . Vertigo: 20mg 3 times daily . |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |